Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Headache
|
May 22, 2018
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial
David W Dodick, Stewart J Tepper, Deborah I Friedman, et al.
Cephalalgia : an International Journal of Headache
|
October 13, 2017
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
Egilius Lh Spierings, Jan Lewis Brandes, David B Kudrow, et al.
Platelets
|
July 27, 2007
Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589
Fred L Johnson, José L Boyer, Philip T Leese, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Headache
|
May 22, 2018
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial
David W Dodick, Stewart J Tepper, Deborah I Friedman, et al.
Cephalalgia : an International Journal of Headache
|
October 13, 2017
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
Egilius Lh Spierings, Jan Lewis Brandes, David B Kudrow, et al.
Platelets
|
July 27, 2007
Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589
Fred L Johnson, José L Boyer, Philip T Leese, et al.
Page
of 2